Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes. 2012

Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
National Institute of Mental Health Collaborative Program on the Psychobiology of Depression, Clinical Studies, USA. ljudd@ucsd.edu

BACKGROUND There is increasing evidence that subsyndromal manic symptoms occur frequently during bipolar major depressive episodes (MDEs) and may be a subtle form of 'depressive mixed state.' This paper examines the prevalence and clinical characteristics of MDEs with subsyndromal manic symptoms. The specific effects of overt irritability and psychomotor agitation are examined. METHODS Bipolar (type I or II) patients with an MDE at intake (N=142) were compared based on the presence or absence of concurrent subsyndromal manic symptoms. The groups were further subdivided by the presence of symptoms of overt irritability and/or psychomotor agitation. RESULTS Subsyndromal manic symptoms during bipolar MDEs were highly prevalent (76.1%), and were associated with significantly increased severity of depression/dysphoria in the intake episode, longer episode duration, and more suicidal ideation and behavior (past, current, and during long-term follow-up). Overt irritability and psychomotor agitation were the most prevalent subsyndromal manic symptoms (co-occurring in 57% and 39% of MDEs, respectively), and accounted for most of the negative effects associated with subsyndromal manic symptoms. CONCLUSIONS The findings need to be confirmed in larger samples, which also examine the relationship to adequate antidepressant and/or mood stabilizing treatment. CONCLUSIONS The presence of one or more subsyndromal manic symptoms appears to be the modal presentation of bipolar MDEs and a marker for a subtle form of bipolar mixed depressive state. In particular, patients with symptoms of overt irritability and/or psychomotor agitation should be monitored closely to avoid serious clinical outcomes such as longer affective episodes, exacerbation of manic symptoms syndromal mania, and heightened suicidality.

UI MeSH Term Description Entries
D007508 Irritable Mood Abnormal or excessive excitability with easily triggered anger, annoyance, or impatience. Mood, Irritable,Irritable Moods,Moods, Irritable
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011595 Psychomotor Agitation A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions. Agitation, Psychomotor,Akathisia,Excitement, Psychomotor,Restlessness,Psychomotor Hyperactivity,Psychomotor Restlessness,Hyperactivity, Psychomotor,Psychomotor Excitement,Restlessness, Psychomotor
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
May 2007, Bipolar disorders,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
January 2016, Neuropsychiatric disease and treatment,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
March 2004, CNS spectrums,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
August 1997, Journal of affective disorders,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
August 2024, Journal of affective disorders,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
October 2023, Clinical child psychology and psychiatry,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
April 2008, Journal of affective disorders,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
February 2021, Journal of affective disorders,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
February 2005, Journal of affective disorders,
Lewis L Judd, and Pamela J Schettler, and Hagop Akiskal, and William Coryell, and Jan Fawcett, and Jess G Fiedorowicz, and David A Solomon, and Martin B Keller
September 2022, Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
Copied contents to your clipboard!